Rick Carpenter - 15 Feb 2024 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
Chief Technology Officer
Signature
/s/ Rachel Malina, Attorney-in-Fact for Rick A. Carpenter
Issuer symbol
TNDM
Transactions as of
15 Feb 2024
Net transactions value
-$5,951
Form type
4
Filing time
20 Feb 2024, 19:27:47 UTC
Previous filing
19 Dec 2023
Next filing
19 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $0 +596 +11% $0.000000 6,085 15 Feb 2024 Direct
transaction TNDM Common Stock Tax liability $5,951 -245 -4% $24.29 5,840 15 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Options Exercise $0 -596 -17% $0.000000 2,978 15 Feb 2024 Common Stock 596 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
F2 Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).
F3 Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
F4 RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.